Regulation of glucose metabolism by MuRF1 and treatment of myopathy in diabetic mice with small molecules targeting MuRF1

The muscle-specific ubiquitin ligase MuRF1 regulates muscle catabolism during chronic wasting states, although its roles in general metabolism are less-studied. Here, we metabolically profiled MuRF1-deficient knockout mice. We also included knockout mice for MuRF2 as its closely related gene homolog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Labeit, Siegfried (VerfasserIn) , Hirner, Stephanie (VerfasserIn) , Bogomolovas, Julijus (VerfasserIn) , Cruz, André (VerfasserIn) , Myrzabekova, Moldir (VerfasserIn) , Moriscot, Anselmo (VerfasserIn) , Bowen, Thomas Scott (VerfasserIn) , Adams, Volker (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 February 2021
In: International journal of molecular sciences
Year: 2021, Jahrgang: 22, Heft: 4, Pages: 1-14
ISSN:1422-0067
DOI:10.3390/ijms22042225
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/ijms22042225
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1422-0067/22/4/2225
Volltext
Verfasserangaben:Siegfried Labeit, Stephanie Hirner, Julijus Bogomolovas, André Cruz, Moldir Myrzabekova, Anselmo Moriscot, Thomas Scott Bowen and Volker Adams

MARC

LEADER 00000caa a2200000 c 4500
001 1757004408
003 DE-627
005 20230426114222.0
007 cr uuu---uuuuu
008 210503s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/ijms22042225  |2 doi 
035 |a (DE-627)1757004408 
035 |a (DE-599)KXP1757004408 
035 |a (OCoLC)1341407795 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Labeit, Siegfried  |d 1960-  |e VerfasserIn  |0 (DE-588)1033566837  |0 (DE-627)741562375  |0 (DE-576)381187314  |4 aut 
245 1 0 |a Regulation of glucose metabolism by MuRF1 and treatment of myopathy in diabetic mice with small molecules targeting MuRF1  |c Siegfried Labeit, Stephanie Hirner, Julijus Bogomolovas, André Cruz, Moldir Myrzabekova, Anselmo Moriscot, Thomas Scott Bowen and Volker Adams 
264 1 |c 23 February 2021 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.05.2021 
520 |a The muscle-specific ubiquitin ligase MuRF1 regulates muscle catabolism during chronic wasting states, although its roles in general metabolism are less-studied. Here, we metabolically profiled MuRF1-deficient knockout mice. We also included knockout mice for MuRF2 as its closely related gene homolog. MuRF1 and MuRF2-KO (knockout) mice have elevated serum glucose, elevated triglycerides, and reduced glucose tolerance. In addition, MuRF2-KO mice have a reduced tolerance to a fat-rich diet. Western blot and enzymatic studies on MuRF1-KO skeletal muscle showed perturbed FoxO-Akt signaling, elevated Akt-Ser-473 activation, and downregulated oxidative mitochondrial metabolism, indicating potential mechanisms for MuRF1,2-dependent glucose and fat metabolism regulation. Consistent with this, the adenoviral re-expression of MuRF1 in KO mice normalized Akt-Ser-473, serum glucose, and triglycerides. Finally, we tested the MuRF1/2 inhibitors MyoMed-205 and MyoMed-946 in a mouse model for type 2 diabetes mellitus (T2DM). After 28 days of treatment, T2DM mice developed progressive muscle weakness detected by wire hang tests, but this was attenuated by the MyoMed-205 treatment. While MyoMed-205 and MyoMed-946 had no significant effects on serum glucose, they did normalize the lymphocyte-granulocyte counts in diabetic sera as indicators of the immune response. Thus, small molecules directed to MuRF1 may be useful in attenuating skeletal muscle strength loss in T2DM conditions. 
650 4 |a chemical biology 
650 4 |a diabetes mellitus 
650 4 |a glucose and muscle metabolism 
650 4 |a MuRF1 
650 4 |a MuRF2 
700 1 |a Hirner, Stephanie  |e VerfasserIn  |4 aut 
700 1 |a Bogomolovas, Julijus  |e VerfasserIn  |4 aut 
700 1 |a Cruz, André  |e VerfasserIn  |4 aut 
700 1 |a Myrzabekova, Moldir  |e VerfasserIn  |4 aut 
700 1 |a Moriscot, Anselmo  |e VerfasserIn  |4 aut 
700 1 |a Bowen, Thomas Scott  |e VerfasserIn  |4 aut 
700 1 |a Adams, Volker  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t International journal of molecular sciences  |d Basel : Molecular Diversity Preservation International, 2000  |g 22(2021), 4, Artikel-ID 2225, Seite 1-14  |h Online-Ressource  |w (DE-627)316340715  |w (DE-600)2019364-6  |w (DE-576)281194653  |x 1422-0067  |7 nnas  |a Regulation of glucose metabolism by MuRF1 and treatment of myopathy in diabetic mice with small molecules targeting MuRF1 
773 1 8 |g volume:22  |g year:2021  |g number:4  |g elocationid:2225  |g pages:1-14  |g extent:14  |a Regulation of glucose metabolism by MuRF1 and treatment of myopathy in diabetic mice with small molecules targeting MuRF1 
856 4 0 |u https://doi.org/10.3390/ijms22042225  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1422-0067/22/4/2225  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210503 
993 |a Article 
994 |a 2021 
998 |g 1033566837  |a Labeit, Siegfried  |m 1033566837:Labeit, Siegfried  |d 60000  |d 61600  |e 60000PL1033566837  |e 61600PL1033566837  |k 0/60000/  |k 1/60000/61600/  |p 1  |x j 
999 |a KXP-PPN1757004408  |e 392175660X 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Siegfried Labeit, Stephanie Hirner, Julijus Bogomolovas, André Cruz, Moldir Myrzabekova, Anselmo Moriscot, Thomas Scott Bowen and Volker Adams"]},"person":[{"family":"Labeit","display":"Labeit, Siegfried","role":"aut","given":"Siegfried"},{"family":"Hirner","role":"aut","given":"Stephanie","display":"Hirner, Stephanie"},{"role":"aut","given":"Julijus","display":"Bogomolovas, Julijus","family":"Bogomolovas"},{"family":"Cruz","given":"André","role":"aut","display":"Cruz, André"},{"family":"Myrzabekova","display":"Myrzabekova, Moldir","given":"Moldir","role":"aut"},{"family":"Moriscot","given":"Anselmo","role":"aut","display":"Moriscot, Anselmo"},{"display":"Bowen, Thomas Scott","role":"aut","given":"Thomas Scott","family":"Bowen"},{"display":"Adams, Volker","given":"Volker","role":"aut","family":"Adams"}],"recId":"1757004408","origin":[{"dateIssuedDisp":"23 February 2021","dateIssuedKey":"2021"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"14 S."}],"id":{"eki":["1757004408"],"doi":["10.3390/ijms22042225"]},"relHost":[{"part":{"issue":"4","pages":"1-14","extent":"14","volume":"22","text":"22(2021), 4, Artikel-ID 2225, Seite 1-14","year":"2021"},"language":["eng"],"title":[{"title_sort":"International journal of molecular sciences","title":"International journal of molecular sciences"}],"pubHistory":["1.2000 -"],"recId":"316340715","origin":[{"publisherPlace":"Basel","dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisher":"Molecular Diversity Preservation International"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"IJMS"}],"note":["Gesehen am 17.09.20"],"disp":"Regulation of glucose metabolism by MuRF1 and treatment of myopathy in diabetic mice with small molecules targeting MuRF1International journal of molecular sciences","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1422-0067","1661-6596"],"zdb":["2019364-6"],"eki":["316340715"]}}],"note":["Gesehen am 03.05.2021"],"title":[{"title":"Regulation of glucose metabolism by MuRF1 and treatment of myopathy in diabetic mice with small molecules targeting MuRF1","title_sort":"Regulation of glucose metabolism by MuRF1 and treatment of myopathy in diabetic mice with small molecules targeting MuRF1"}],"language":["eng"]} 
SRT |a LABEITSIEGREGULATION2320